A detailed history of Systm Wealth Solutions LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Systm Wealth Solutions LLC holds 1,852 shares of GILD stock, worth $156,660. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,852
Previous 2,188 15.36%
Holding current value
$156,660
Previous $160 Million 20.72%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$63.15 - $72.88 $21,218 - $24,487
-336 Reduced 15.36%
1,852 $127 Million
Q1 2024

Apr 26, 2024

BUY
$71.58 - $87.29 $3,579 - $4,364
50 Added 2.34%
2,188 $160 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $54,439 - $61,735
-743 Reduced 25.79%
2,138 $173 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $213,021 - $232,410
2,881 New
2,881 $216 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $837,954 - $1.2 Million
13,446 New
13,446 $1.15 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $106B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Systm Wealth Solutions LLC Portfolio

Follow Systm Wealth Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systm Wealth Solutions LLC with notifications on news.